Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer

Published:2012-12-12 Issue:24 Volume:104 Page:1879-1887
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Groheux D.,Hindie E.,Delord M.,Giacchetti S.,Hamy A.-s.,de Bazelaire C.,de Roquancourt A.,Vercellino L.,Toubert M.-E.,Merlet P.,Espie M.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/104/24/1879/7674836/djs451.pdf

Reference28 articles.

1. Should FDG PET/CT be used for the initial staging of breast cancer?

2. The Sentinel Node Procedure in Breast Cancer: Nuclear Medicine as the Starting Point

3. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings

4. Retrospective Study of 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data

5. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of [18F]FDG PET/CT in patients with no special type breast cancer: Literature review and comparison between guidelines;The Breast;2024-09

2. Comparison of 18F-FDG PET/CT and 18F-FAPI PET/CT in Systemic Staging of Newly Diagnosed Breast Cancer;Academic Radiology;2024-09

3. The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-07

4. 18F-FDG PET/CT for early prediction of pathological complete response in breast cancer neoadjuvant therapy: a retrospective analysis;The Oncologist;2024-07-23

5. Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer;Breast Cancer Research and Treatment;2024-06-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3